GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Universal Health International Group Holding Ltd (HKSE:02211) » Definitions » 3-Year EBITDA Growth Rate

Universal Health International Group Holding (HKSE:02211) 3-Year EBITDA Growth Rate : 48.10% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Universal Health International Group Holding 3-Year EBITDA Growth Rate?

Universal Health International Group Holding's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was 48.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Universal Health International Group Holding was 48.10% per year. The lowest was -213.40% per year. And the median was -1.90% per year.


Competitive Comparison of Universal Health International Group Holding's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Universal Health International Group Holding's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Health International Group Holding's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Universal Health International Group Holding's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Universal Health International Group Holding's 3-Year EBITDA Growth Rate falls into.



Universal Health International Group Holding 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Universal Health International Group Holding  (HKSE:02211) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Universal Health International Group Holding 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Universal Health International Group Holding's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Health International Group Holding (HKSE:02211) Business Description

Traded in Other Exchanges
N/A
Address
No. 14-1, Bei Yi Zhong Road, Tiexi District, Liaoning Province, Shenyang, CHN
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. It sells prescription and OTC products, healthcare products, medical devices, and other personal and family care products. The company operates its business through two segments: Distributions and Retails, out of which, majority of revenue is earned by Distributions Segment.

Universal Health International Group Holding (HKSE:02211) Headlines

No Headlines